0001209191-15-024198.txt : 20150309
0001209191-15-024198.hdr.sgml : 20150309
20150309181737
ACCESSION NUMBER: 0001209191-15-024198
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140617
FILED AS OF DATE: 20150309
DATE AS OF CHANGE: 20150309
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NOVAVAX INC
CENTRAL INDEX KEY: 0001000694
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 222816046
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 20 FIRSTFIELD ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
BUSINESS PHONE: 240-268-2000
MAIL ADDRESS:
STREET 1: 20 FIRSTFIELD ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MCMANUS MICHAEL A JR
CENTRAL INDEX KEY: 0001051997
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26770
FILM NUMBER: 15686497
MAIL ADDRESS:
STREET 1: 241-02 NORTHERN BLVD
CITY: DOUGLASTON
STATE: NY
ZIP: 11362
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2014-06-17
0
0001000694
NOVAVAX INC
NVAX
0001051997
MCMANUS MICHAEL A JR
C/O NOVAVAX, INC.
20 FIRSTFIELD ROAD
GAITHERSBURG
MD
20878
1
0
0
0
Common Stock
2014-06-17
4
M
0
15000
0.56
A
137590
D
Common Stock
2014-06-17
4
M
0
30000
1.28
A
167590
D
Stock Option (Right to buy)
0.56
2014-06-17
4
M
0
15000
0.00
D
2009-09-05
2019-03-05
Common Stock
15000
0
D
Stock Option (Right to buy)
1.28
2014-06-17
4
M
0
30000
0.00
D
2012-09-01
2022-03-01
Common Stock
30000
0
D
Stock Option (Right to buy)
8.94
2015-03-05
4
A
0
40000
0.00
A
2015-09-05
2025-03-05
Common Stock
40000
40000
D
This option grant was approved by a committee of Novavax's board of directors on March 5, 2015, subject to shareholder approval of the Novavax, Inc. 2015 Stock Incentive Plan.
/s/ John A. Herrmann III, Attorney-in-Fact
2015-03-09